DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 3 INFECTION: INTERIM ANALYSIS OF A FRENCH MULTICENTER COMPASSIONATE USE PROGRAM

Affiliation auteurs!!!! Error affiliation !!!!
TitreDACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 3 INFECTION: INTERIM ANALYSIS OF A FRENCH MULTICENTER COMPASSIONATE USE PROGRAM
Type de publicationJournal Article
Year of Publication2015
AuteursHezode C., De Ledinghen V., Fontaine H., Zoulim F., Lebray P., Boyer N., Larrey D., Silvain C., Botta-Fridlund D., Leroy V., Bourliere M., D'alteroche L., Hubert-Fouchard I., Guyader D., Rosa I., Nguyen-Khac E., Di Martino V., Carrat F., Fedchuk L., Akremi R., Bennai Y., Bronowicki J.-P, Squibb BMyers, Cohort ANRSCO22-Hepat
JournalJOURNAL OF HEPATOLOGY
Volume62
PaginationS265-S266
Date PublishedAPR
Type of ArticleMeeting Abstract
ISSN0168-8278
DOI10.1016/S0168-8278(15)30159-8